Mitchell Sinkler & Starr Bristol Myers Squibb CO Transaction History

Mitchell Sinkler & Starr

$370 Million
Q4 2024

A detailed history of Mitchell Sinkler & Starr transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 8,890 shares of BMY stock, worth $479,171. This represents 0.14% of its overall portfolio holdings.

Number of Shares

8,890

Previous 9,490 6.32%

Holding current value

$479,171

Previous $491,000 2.24%

% of portfolio

0.14%

Previous 0.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$51.92 - $59.94 $31,152 - $35,964	-600 Reduced 6.32%	8,890 $502,000
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $19,235 - $25,098	485 Added 5.39%	9,490 $491,000
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $344,540 - $453,594	-8,560 Reduced 48.73%	9,005 $373,000
Q1 2024 Apr 30, 2024	SELL	$47.98 - $54.4 $459,504 - $520,988	-9,577 Reduced 35.28%	17,565 $952,000
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $588,401 - $702,125	12,137 Added 80.89%	27,142 $1.39 Million
Q3 2023 Nov 01, 2023	BUY	$57.89 - $64.73 $129,094 - $144,347	2,230 Added 17.46%	15,005 $870,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $479,354 - $543,696	-7,295 Reduced 36.35%	12,775 $885,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $640,972 - $759,002	9,360 Added 87.39%	20,070 $1.44 Million
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $176 - $104,502	1,360 Added 14.55%	10,710 $761,000
Q2 2022 Jul 21, 2022	SELL	$72.62 - $79.98 $18,881 - $20,794	-260 Reduced 2.71%	9,350 $720,000
Q1 2022 Apr 19, 2022	SELL	$61.48 - $73.72 $10,759 - $12,901	-175 Reduced 1.79%	9,610 $702,000
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $17,751 - $20,793	-300 Reduced 2.97%	9,785 $579,000
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $3,095 - $3,371	50 Added 0.5%	10,085 $674,000
Q1 2021 Apr 12, 2021	SELL	$59.34 - $66.74 $29,670 - $33,370	-500 Reduced 4.75%	10,035 $634,000
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $28,870 - $32,715	-500 Reduced 4.53%	10,535 $653,000
Q3 2019 Nov 06, 2019	BUY	$42.77 - $50.71 $147,556 - $174,949	3,450 Added 45.48%	11,035 $560,000
Q2 2019 Jul 17, 2019	SELL	$44.62 - $49.34 $43,058 - $47,613	-965 Reduced 11.29%	7,585 $344,000
Q1 2019 Apr 08, 2019	SELL	$45.12 - $53.8 $90,240 - $107,600	-2,000 Reduced 18.96%	8,550 $408,000
Q3 2018 Oct 04, 2018	SELL	$55.19 - $62.25 $55,190 - $62,250	-1,000 Reduced 8.66%	10,550 $655,000
Q2 2018 Jul 11, 2018	SELL	$50.53 - $62.98 $219,805 - $273,963	-4,350 Reduced 27.36%	11,550 $639,000
Q1 2018 Apr 13, 2018	SELL	$59.92 - $68.98 $10,486 - $12,071	-175 Reduced 1.09%	15,900 $1.01 Million
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $887,822 - $1.02 Million	16,075	16,075 $1.03 Million

Others Institutions Holding BMY

# of Institutions

2,729

Shares Held

1.57B

Call Options Held

30M

Put Options Held

31.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.

Account

Mitchell Sinkler & Starr Bristol Myers Squibb CO Transaction History